H2020 2016-2017 NH C2VT2

1. Santé, Démographie, bien-être Personalised Medecine Date limite: 16 février 2016

1.1. SC1-PM-18-2016:Big Data supporting Public Health policies ;

1.2. SC1-PM-13-2016:PPI for deployment and scaling up of ICT solutions for active and healthy ageing ;

1.3. SC1-PM-12-2016:PCP - eHealth innovation in empowering the patient ;

1.4. SC1-HCO-16-2016:Standardisation needs in the field of ICT for Active and Healthy Ageing ;

1.5. SC1-HCO-15-2016:EU eHealth Interoperability conformity assessment ;

1.6. SC1-HCO-13-2016:Healthcare Workforce IT skills ;

1.7. SC1-HCO-12-2016:Digital health literacy ;

1.8. SC1-HCO-11-2016:Coordinated action to support the recognition of Silver Economy opportunities arising from demographic change ;

1.9. SC1-HCO-10-2016:Support for Europe’s leading Health ICT SMEs.

2. Santé, Démographie, bien-être Personalised Medecine Date limite: 13 avril 2016

2.1. SC1-PM-21-2016 : Implementation research for scaling-up of evidence based innovations and good practice in Europe and low- and middle-income countries ;

2.2. SC1-PM-11-2016-2017 : Clinical research on regenerative medicine ;

2.3. SC1-PM-09-2016 : New therapies for chronic diseases ;

2.4. SC1-PM-06-2016 : Vaccine development for malaria and/or neglected infectious diseases ;

2.5. SC1-PM-05-2016 : The European Human Biomonitoring Initiative ;

2.6. SC1-PM-04-2016 : Networking and optimising the use of population and patient cohorts at EU level ;

2.7. SC1-PM-01-2016 : Multi omics for personalised therapies addressing diseases of the immune system ;

2.8. SC1-HCO-06-2016 : Towards an ERA-NET for building sustainable and resilient health system models ;

2.9. SC1-HCO-05-2016 : Coordinating personalised medicine research ;

2.10. SC1-HCO-04-2016 : Towards globalisation of the Joint Programming Initiative on Antimicrobial resistance ;

2.11. SC1-HCO-02-2016 : Standardisation of pre-analytical and analytical procedures for in vitro diagnostics in personalised medicine ;

2.12. SC1-HCO-01-2016 : Valorisation of FP7 Health and H2020 SC1 research results.

3. Industrial Leadership CALL FOR NANOTECHNOLOGIES, ADVANCED MATERIALS, BIOTECHNOLOGY AND PRODUCTION NMBP-11-2016:ERA-NET on Nanomedicine Deadline: 21 January 2016 17:00:00

3.1. NMBP-10-2016 (RIA) :Nanoformulation of biologicals Tow stage Deadline: 08 December 2015 17:00:00/ 24 May 2016 17:00:00

3.2. NMBP-27-2016 (CSA ):Promoting safe innovation through global consolidation and networking of nanosafety centres and strengthening the European industry through cooperation in nanosafety Single-stage Deadline: 21 January 2016 17:00:00

3.3. Topic: NMBP-30-2016 (CSA) :Facilitating knowledge management, networking and coordination in the field of formulated products Single-stage Deadline: 21 January 2016 17:00:00

3.4. NMBP-09-2016 (RIA) :Biomaterials for diagnosis and treatment of demyelination disorders of the Central Nervous System

3.5. BIOTEC-03-2016:Microbial chassis platforms with optimized metabolic pathways for industrial innovations through systems biology Deadline Model: two-stage Deadline: 08 December 2015 17:00:00 / 2nd stage Deadline: 24 May 2016 17:00:00

3.6. BIOTEC-04-2016 (CSA) : KET Biotechnology foresight identifying gaps and high-value opportunities for the EU industry.

3.7. BIOTEC-01-2016:ERA-NET Cofund on Biotechnologies , Deadline: 21 January 2016 17:00:00

3.8. NMBP-09-2016( RIA ) :Biomaterials for diagnosis and treatment of demyelination disorders of the Central Nervous System Tow stages, Deadline: 08 December 2015 17:00:00/ 24 May 2016 17:00:00

3.9. BIOTEC-02-2016:Bioconversion of non-agricultural waste into biomolecules for industrial applications 2nd stage Deadline: 08 December 2015 17:00

3.10. CALL FOR NANOTECHNOLOGIES, ADVANCED MATERIALS, BIOTECHNOLOGY AND PRODUCTION NMBP-11-2016:ERA-NET on Nanomedicine Deadline: 21 January 2016 17:00:00

4. Actions Marie Sklodowska-Curie